期刊文献+

爱诺华

下载PDF
导出
摘要 爱诺华是第一个美国FDA批准的、针对类风湿关节炎、可改变病程及减轻骨质破坏的病程改善药;是国家一类新药;第一个使中国病人与发达国家病人同步使用的突破性药物;也是一种属于异唑类化合物的新型低毒的免疫调节剂.在美国上市一年多来,已有超过76000例类风湿关节炎病人长期服用来氟米特.现对该药做一介绍.
作者 黄晓舞
出处 《中国药物应用与监测》 CAS 2002年第4期60-61,共2页 Chinese Journal of Drug Application and Monitoring
  • 相关文献

参考文献7

二级参考文献13

  • 1[1] Barlett RR,Anagnostopulos H,Zielinski T,et al.Effects of leflun o mide on immune responses and models of inflammation.Springer Semin Immunopathal, 1993,14∶381-394.
  • 2[2] Weaver A, Caldwell J, Olsen N et al. Treatment of active rheumat oid arthritis with leflunomide compared to placebo or methotrexate. ACR Concurre nt Session,1998, Abstract∶593.
  • 3[3] Finnegan A,Siemasko K F,Williams J W,et al.Leflunomide inhibits immunog lobin prodution by two separate mechanism.ACR Poster Session,1997,40.
  • 4[4] Barlett R.R,et al. Leflunomide, an imunorestoring drug for the therapy autoimmune disorders, especially rheumatoid. Current Opinion in Rheumatoid, 199 7,9∶410.
  • 5[5] Prakash M, Jarvis B. Leflunomide, a review of its use in active rheumat oid arthritis.1999,58(6)∶1137-1164.
  • 6[6] Weinblatt ME, Kremer JM, Coblyn JS,et al. Leflunomide plus methotrexate in refractory rheumatoid arthritis: A pilot study. ACR Poster Session,1997,Abs tract∶974.
  • 7Smolen SJ,Kalden RJ,Scott LD,et al.Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a doubleblind, randomised, multicentre trial[].The Lancet.1999
  • 8Fox RI.Mechanism of action of leflunomide in rheumatoid arthritis[].The Journal of Rheumatology.1998
  • 9Smolen JS,Kalden JR,Scott DI,et al.Efficacy and safety of leflunomide compared with placebo and sulphsalazine in active rheumatoid arthritis: a doubleblind, randomised, multicentre trial[].The Lancet.1999
  • 10Fox RI.Mechanism of action of leflunomide in rheumatoid arthritis[].Journal of Rheumatology The.1998

共引文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部